Investigator

Sara Ravaioli

Post-doctoral researcher · IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Biosciences Laboratory

SRSara Ravaioli
Papers(1)
An initiative to asse…
Collaborators(1)
Sara Bravaccini
Institutions(1)
Istituto Scientifico …

Papers

An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection

The aim of our study was to assess the quality of Tanzanian cervical cancer specimens, evaluating telomerase alterations and human papilloma virus (HPV) infection in relation to histopathological characteristics since these biomarkers are not routinely analyzed. Thirty-two Tanzanian women with invasive cervical cancer were included in the study. Histopathological classification and all the analyses on tissue, including TERT immunohistochemistry, were performed at IRST IRCCS (Meldola, Italy). HPV typization was performed by pyrosequencing. FHACT™ was used to identify chromosomal aberrations. Nonparametric ranking statistics were used. The majority (75 %) of the cases analyzed were squamous carcinoma, while 12.5 % were adenocarcinoma. The presence of HPV infection was confirmed in 26/27 (96.3 %) cases. A high percentage of patients (88 %) were infected with HPV16 of whom 12 (44.4 %) with African type 1, and 4 (14.8 %) with African type 2. TERT expression evaluated in the entire case series showed a median H-score of 130 (range 3-270), with only one negative case. 88 % of the FISH-evaluable samples showed an amplification of the chromosomal region 3q26 (TERC) and/or 5p15, and 20q13, associated with a higher median expression of TERT (P = 0.0226). Despite pre-analytical problems in terms of sample fixation, we showed that the search for biomarkers such as HPV and telomerase is feasible in Tanzanian tissue. These markers could be important risk-stratification tools in this population.

34Works
1Papers
1Collaborators
Breast NeoplasmsBiomarkers, TumorPrognosisDrug Resistance, NeoplasmPancreatic NeoplasmsTumor MicroenvironmentGenetic Predisposition to Disease

Positions

2015–

Post-doctoral researcher

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori · Biosciences Laboratory

Education

2014

LAUREA MAGISTRALE IN BIOTECNOLOGIE MEDICHE E MEDICINA MOLECOLARE

Universita degli Studi di Milano Dipartimento di Scienze della Salute · Dipartimento di Scienze della Salute

2012

LAUREA TRIENNALE IN BIOTECNOLOGIE

Università di Bologna · SCIENZE MATEMATICHE FISICHE E NATURALI

Country

IT